NFE2L2 and lysosomal storage disease: Therefore, it would be worthwhile to examine whether (1) NRF2 and associated pathways are affected in INCL (and indeed other lysosomal storage disorders); and (2) whether NRF2 activator compounds may be used to mitigate the oxidative stress pathology observed in INCL fibroblasts.